Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 22480336)

1.

Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis.

Fretheim A, Odgaard-Jensen J, Brørs O, Madsen S, Njølstad I, Norheim OF, Svilaas A, Kristiansen IS, Thürmer H, Flottorp S.

BMC Med. 2012 Apr 5;10:33. doi: 10.1186/1741-7015-10-33. Review.

2.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
3.

Beta-blockers for hypertension.

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH.

Cochrane Database Syst Rev. 2012 Aug 15;8:CD002003. doi: 10.1002/14651858.CD002003.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002003.

PMID:
22895924
4.

Beta-blockers for hypertension.

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD002003. doi: 10.1002/14651858.CD002003.pub4. Review.

PMID:
23152211
6.

First-line drugs for hypertension.

Wright JM, Musini VM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001841. doi: 10.1002/14651858.CD001841.pub2. Review.

PMID:
19588327
7.

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Staessen JA, Wang JG, Thijs L.

J Hypertens. 2003 Jun;21(6):1055-76.

PMID:
12777939
8.

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.

JAMA. 2003 May 21;289(19):2534-44.

PMID:
12759325
9.

Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.

Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P.

J Hypertens. 2008 Jul;26(7):1282-9. doi: 10.1097/HJH.0b013e328306ebe2.

PMID:
18550998
10.

Calcium channel blockers versus other classes of drugs for hypertension.

Chen N, Zhou M, Yang M, Guo J, Zhu C, Yang J, Wang Y, Yang X, He L.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD003654. doi: 10.1002/14651858.CD003654.pub4. Review.

PMID:
20687074
11.

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD.

JAMA. 1997 Mar 5;277(9):739-45.

PMID:
9042847
12.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.

Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.

Ann Intern Med. 2009 Dec 15;151(12):861-71. doi: 10.7326/0003-4819-151-12-200912150-00162. Review.

PMID:
20008762
13.

Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.

Suzuki H, Kanno Y; Efficacy of Candesartan on Outcome in Saitama Trial (E-COST) Group.

Hypertens Res. 2005 Apr;28(4):307-14. Erratum in: Hypertens Res. 2005 Jun;28(6):553.

PMID:
16138560
14.

New-onset diabetes and antihypertensive treatment.

Grimm C, Köberlein J, Wiosna W, Kresimon J, Kiencke P, Rychlik R.

GMS Health Technol Assess. 2010 Mar 16;6:Doc03. doi: 10.3205/hta000081.

15.

Effect of aspirin on mortality in the primary prevention of cardiovascular disease.

Raju N, Sobieraj-Teague M, Hirsh J, O'Donnell M, Eikelboom J.

Am J Med. 2011 Jul;124(7):621-9. doi: 10.1016/j.amjmed.2011.01.018. Epub 2011 May 17.

PMID:
21592450
16.

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.

Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH.

J Hypertens. 2006 Nov;24(11):2131-41. Review.

PMID:
17053529
17.

Clinical efficacies of antihypertensive drugs.

Aursnes I, Tvete IF, Gåsemyr J, Natvig B.

Scand Cardiovasc J. 2003 May;37(2):72-9.

PMID:
12775305
18.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
19.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

20.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk